AGP18 Antibody

Shipped with Ice Packs
In Stock

Description

Female Gametogenesis

AGP18 is essential for initiating female gametogenesis in Arabidopsis. RNA interference (RNAi)-mediated silencing of AGP18 results in 75% reduced seed set, with defects localized to female reproductive structures .

Megaspore Selection and Survival

AGP18 promotes the survival of functional megaspores (FM) post-meiosis. Overexpression of AGP18 leads to 24% of ovules developing supernumerary cells, which express FM markers like ProFM2-GUS. This indicates AGP18's role in maintaining viable megaspores .

Protein Structure

AGP18 features:

  • N-terminal secretory signal for endoplasmic reticulum targeting.

  • C-terminal GPI anchor for plasma membrane attachment.

  • Lysine-rich domain for interaction with negatively charged molecules .

Expression Patterns

Studies using proAGP18 promoter-GUS fusions and immunolocalization reveal:

Promoter ConstructExpression Pattern
1622-GUSSporophytic cells in abaxial ovule integuments; expands to nucellar cells post-meiosis
1217-GUSStrong sporophytic expression; lacks gametophytic expression
559-GUSWeak sporophytic expression; antipodal cell localization

AGP18 localizes to plasma membranes and cytoplasmic foci in sporophytic cells adjacent to the megaspore mother cell (MMC) . Post-meiosis, it polarizes toward the FM .

Functional Insights from Overexpression Studies

Transgenic Arabidopsis overexpressing AGP18 exhibit:

  • Abnormal megaspore persistence: Multiple meiotically derived cells acquire FM identity.

  • Reduced fertility: Linked to incomplete megaspore selection and developmental arrest.

  • Sporophytic-gametophytic interplay: AGP18 expression bridges maternal tissues and the developing gametophyte .

Applications in Research

The AGP18 Antibody has been pivotal in:

  1. Localization studies: Tracking AGP18 distribution via cMyc/6XHis epitope tagging .

  2. Functional assays: Validating RNAi silencing effects on ovule development .

  3. Mechanistic insights: Linking GPI-anchored AGPs to cell signaling during gametogenesis .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
AGP18 antibody; At4g37450 antibody; F6G17.100Lysine-rich arabinogalactan protein 18 antibody; Lys-rich AGP 18 antibody
Target Names
AGP18
Uniprot No.

Target Background

Function
Arabinogalactan protein 18 (AGP18) is a proteoglycan implicated in various developmental processes, including differentiation, cell-cell recognition, embryogenesis, and programmed cell death.
Gene References Into Functions
  • Meiotic expression of AGP18 is observed in abaxial integumentary cells of the ovule. (PMID: 23572547)
  • AGP18 is proposed as a glycosylphosphatidylinositol (GPI)-anchored protein, potentially involved in signal transduction pathways regulating plant growth and development. (PMID: 21849816)
  • Overexpression of AtAGP18 results in distinct phenotypic alterations compared to wild-type plants. (PMID: 21165646)
  • AtAGP18 exhibits organ- and tissue-specific expression patterns and subcellular localization, differing from other Lys-rich AGPs. High expression is observed in roots, flowers, and stems, with weaker expression in seedlings and rosettes. (PMID: 17294240)
Database Links

KEGG: ath:AT4G37450

STRING: 3702.AT4G37450.1

UniGene: At.2789

Protein Families
Lysine-rich AGP family
Subcellular Location
Cell membrane; Lipid-anchor, GPI-anchor.
Tissue Specificity
Predominantly expressed in flowers, and moderately expressed in roots, stems and young leaves.

Q&A

What is AGP18 and why are antibodies against it important for plant reproductive research?

AGP18 is a classical arabinogalactan protein that exerts active regulation over the selection and survival of megaspores following meiosis in Arabidopsis thaliana. It is essential for the initiation of female gametogenesis, with AGP18-deficient plants showing arrested functional megaspores before the first haploid mitotic division .

Antibodies against AGP18 are valuable research tools that allow for:

  • Precise localization of AGP18 protein in plant tissues

  • Tracking temporal expression patterns during reproductive development

  • Distinguishing between transcriptional and translational regulation

  • Investigating protein-protein interactions involving AGP18

Studies have shown that AGP18 distribution intersects the sporophytic-gametophytic transition, with the protein localizing to the plasma membrane and cytoplasmic foci in specific cell types . This unique distribution pattern makes AGP18 antibodies particularly valuable for studying reproductive development transitions.

What techniques are most effective for validating the specificity of AGP18 antibodies?

Validating antibody specificity is crucial for reliable experimental results. For AGP18 antibodies, researchers should employ multiple validation approaches:

  • Western blot analysis: Compare protein detection in wild-type plants versus AGP18 knockdown/knockout mutants. The absence of signal in mutant lines confirms specificity .

  • Immunolocalization controls: Perform parallel immunostaining in wild-type and AGP18-deficient tissues. Additionally, include controls with secondary antibody only to rule out non-specific binding .

  • Peptide competition assays: Pre-incubate the antibody with purified AGP18 peptide before immunostaining. Signal reduction indicates specificity for the target epitope .

  • Cross-reactivity testing: Test antibody against other classical AGPs (particularly AGP17 and AGP19) that share structural similarities with AGP18 .

  • Epitope mapping: Identify the specific binding region using truncated AGP18 protein variants to ensure the antibody recognizes the intended domain .

It's worth noting that classical AGPs like AGP18 contain an N-terminal signal peptide and a C-terminal GPI anchor attachment domain, which can complicate antibody design and validation .

How should researchers design immunolocalization experiments for AGP18 in plant reproductive tissues?

Effective immunolocalization of AGP18 requires careful consideration of tissue preparation and experimental protocols:

  • Tissue fixation: Use 4% paraformaldehyde in phosphate buffer to preserve protein structure while maintaining tissue morphology .

  • Epitope accessibility: Given that AGP18 can localize to both plasma membrane and cytoplasmic compartments, consider including a mild detergent permeabilization step (0.1-0.3% Triton X-100) .

  • Antibody selection: For optimal detection, use antibodies targeting regions downstream of the N-terminal signal peptide, as this favors exposure of the epitope after potential peptide cleavage .

  • Developmental staging: Carefully stage ovules to capture key developmental transitions, including premeiotic stages, post-meiotic functional megaspore elongation, and mature female gametophyte .

  • Co-labeling strategy: Include cellular markers for plasma membrane, nuclei, and cell boundaries to precisely determine AGP18 subcellular localization .

When analyzing results, note that AGP18 distribution can be polarized, with abundant expression in cellular edges adjacent to the functional megaspore, which is critical for interpreting the protein's function in reproductive development .

What computational approaches can improve the design of highly specific AGP18 antibodies?

Advanced computational methods can significantly enhance the specificity of AGP18 antibodies:

  • Biophysics-informed modeling: This approach associates distinct binding modes with potential ligands, enabling the prediction and generation of specific antibody variants beyond those observed in experiments .

  • Epitope prediction algorithms: Computational tools can identify unique, accessible epitopes in AGP18 that differ from other AGPs, improving antibody specificity.

  • Machine learning integration: Combining high-throughput sequencing data with downstream computational analysis allows for designing antibodies with customized specificity profiles .

  • Binding mode identification: Computational models can disentangle multiple binding modes associated with specific regions of AGP18, critical for distinguishing between closely related epitopes .

As demonstrated in recent research, these computational approaches have been successful in designing antibodies with both specific and cross-specific binding properties, allowing researchers to mitigate experimental artifacts and biases in selection experiments .

How can researchers overcome challenges related to AGP18's post-translational modifications when developing antibodies?

AGP18, like other classical AGPs, undergoes extensive post-translational modifications (PTMs) that can complicate antibody development:

  • Glycosylation-independent epitopes: Target protein regions less likely to be glycosylated, particularly focusing on peptide sequences that don't contain hydroxyproline residues .

  • Enzymatic deglycosylation: Consider treating samples with specific enzymes to remove glycan moieties before immunization or immunodetection, exposing the protein backbone for improved antibody recognition.

  • Recombinant protein strategies: Express non-glycosylated versions of AGP18 subdomains in bacterial systems for immunization, focusing on unique peptide sequences .

  • Synthetic peptide approach: Design synthetic peptides based on AGP18-specific sequences that lack glycosylation sites but retain unique features.

  • Multiple antibody approach: Develop a panel of antibodies targeting different regions of AGP18 to create a comprehensive detection system that accounts for potential PTM variations .

The effective navigation of PTM challenges is critical, as AGP18's functional properties may depend on its glycosylation status, which varies between cell types and developmental stages .

What experimental designs are most effective for studying AGP18's role in female gametophyte development using antibodies?

To effectively investigate AGP18's function in female gametophyte development, consider these advanced experimental approaches:

  • Temporal expression analysis: Conduct time-course immunolocalization experiments at key developmental stages:

    • Premeiotic ovules (AGP18 distributed in sporophytic cells, absent in MMC)

    • Post-meiotic stages (AGP18 expression in functional megaspore during elongation)

    • Mature female gametophyte (AGP18 localized in central cell and egg apparatus)

  • Genetic background comparisons: Compare AGP18 localization patterns in:

    • Wild-type plants

    • AGP18 overexpression lines showing abnormal maintenance of surviving megaspores

    • sporocyteless (spl) mutants lacking the full gametophytic lineage

  • Promoter-reporter fusion analysis: Complement antibody studies with promoter analysis using constructs like:

ConstructRegion IncludedExpression Pattern
proAGP18 1622UTR-GUSComplete intergenic + 5'-UTRIntegumentary cells at base, abaxial region
proAGP18 1622-GUSComplete intergenic regionSimilar to above
proAGP18 1217-GUS-1217 bp fragmentSporophytic expression, no gametophytic expression
proAGP18 559-GUS-559 bp fragmentWeak sporophytic, strong antipodal expression
proAGP18 162-GUS-162 bp fragmentNo ovule expression
  • Co-immunoprecipitation studies: Use AGP18 antibodies to isolate protein complexes and identify interaction partners during megaspore selection and development .

  • In situ hybridization coupled with immunolocalization: Compare mRNA and protein localization to identify post-transcriptional regulation, as previous research showed AGP18 mRNA localization in premeiotic cells precedes protein localization in the gametophytic lineage .

These approaches can reveal the precise spatiotemporal dynamics of AGP18 during female gametophyte development and provide insights into its regulatory mechanisms.

What phage display techniques can be used to develop highly specific AGP18 antibodies?

Phage display offers powerful approaches for developing specific AGP18 antibodies:

  • Library design: Create a minimal antibody library based on a single naïve human VH domain with systematic variation in the third complementarity determining region (CDR3), which allows for high-coverage analysis by high-throughput sequencing .

  • Selection strategy: Perform multiple rounds of selection with amplification steps in between:

    • First round: Incubate phage library with immobilized AGP18 protein

    • Second round: Increase stringency by reducing AGP18 concentration

    • Include negative selection against related AGPs to improve specificity

  • Cross-selection approach: Conduct parallel selections against various combinations of AGP18 and similar proteins to identify antibodies with desired specificity profiles .

  • Sequential analysis: After each selection round, analyze the enriched antibody variants through high-throughput sequencing to track the evolution of the antibody repertoire .

  • Computational integration: Apply biophysics-informed models to the sequence data to identify distinct binding modes associated with specific epitopes, enabling the prediction of novel specific variants beyond those observed in experiments .

This comprehensive approach has been shown to successfully develop antibodies with customized specificity profiles, either with high affinity for particular target epitopes or with cross-specificity for multiple targets .

How can statistical approaches improve the analysis of AGP18 antibody specificity data?

Advanced statistical methods enhance the interpretation of AGP18 antibody specificity data:

When applying these approaches to AGP18 antibody data, researchers should consider the positive correlation among different antibody variants, as this can substantially reduce the number of statistically significant antibodies after controlling for multiple testing .

What immunodetection methods provide the most reliable results for AGP18 localization in plant tissues?

For optimal detection of AGP18 in plant tissues, consider these specialized immunodetection approaches:

  • Antigenic epitope strategies: Introduce antigenic epitopes (cMyc or 6XHis) downstream of the N-terminal signal peptide to favor exposure after potential peptide cleavage, addressing the challenges posed by AGP18's structural features .

  • Multiple controls: Include comprehensive controls:

    • AGP18 knockout/knockdown tissues

    • Secondary antibody-only controls

    • Pre-immune serum controls

    • Competing peptide controls

  • High-resolution imaging: Employ confocal microscopy with optical sectioning to precisely locate AGP18 at subcellular resolution, particularly important for distinguishing membrane-associated from cytoplasmic localization .

  • Tissue-specific fixation protocols: Optimize fixation based on tissue type:

    • For ovules: Use 4% paraformaldehyde with careful timing to preserve delicate structures

    • For vegetative tissues: Modified protocols may be needed to penetrate cuticle

  • Dual immunolocalization: Combine AGP18 antibody detection with markers for specific cellular structures:

    • Plasma membrane markers to confirm membrane localization

    • ER/Golgi markers to track secretory pathway processing

    • Nuclear envelope markers to contextualize the cytoplasmic foci observed adjacent to nuclei

These approaches help overcome the technical challenges of AGP18 detection, including its variable localization patterns and the presence of both membrane-associated and cytoplasmic populations .

How can AGP18 antibodies be used to investigate the sporophytic-gametophytic transition in flowering plants?

AGP18 antibodies offer unique insights into the sporophytic-gametophytic transition:

  • Comparative localization studies: Compare AGP18 protein distribution across key developmental transitions:

    • In premeiotic ovules: AGP18 is distributed uniformly in sporophytic cells but absent in the megaspore mother cell (MMC)

    • After meiosis II: AGP18 is expressed in the functional megaspore during elongation

    • In mature ovules: AGP18 localizes to the central cell and egg apparatus but is absent in antipodals

  • Transcription vs. translation dynamics: Couple in situ hybridization (mRNA) with immunolocalization (protein) to identify:

    • Where AGP18 mRNA localization precedes protein appearance

    • Cell-specific translational regulation

    • Post-translational regulatory mechanisms

  • Regulatory element analysis: Use promoter-reporter constructs alongside antibody detection to map regulatory elements controlling the sporophytic-to-gametophytic expression switch:

    • The -559 to -1 segment containing CArG motifs controls sporophytic expression

    • The -1622 to -1217 segment regulates quantitative expression

    • The -1217 to -559 segment containing a CpG island negatively regulates sporophytic expression

  • Genetic background comparisons: Analyze AGP18 localization in sporocyteless (spl) mutants that lack the female gametophytic lineage to distinguish autonomous vs. gametophyte-dependent expression patterns .

  • Polarized distribution analysis: Investigate the polarized distribution of AGP18 in nucellar cells, with abundant expression in cellular edges adjacent to the functional megaspore, which may reveal intercellular signaling mechanisms .

These approaches can illuminate how AGP18 functions at the critical juncture between sporophytic and gametophytic generations in flowering plants.

What methods can be used to analyze potential cross-reactivity between AGP18 antibodies and other AGP family members?

Analyzing cross-reactivity between AGP18 antibodies and related AGPs requires systematic approaches:

  • Comprehensive sequence analysis: Compare AGP18 with other AGP family members (particularly AGP17 and AGP19) to identify:

    • Unique epitopes specific to AGP18

    • Conserved domains that might lead to cross-reactivity

    • Post-translational modification patterns

  • Biophysics-informed modeling: Apply computational approaches that:

    • Identify different binding modes associated with particular AGP family members

    • Disentangle these modes even when associated with chemically similar proteins

    • Predict cross-reactivity patterns before experimental validation

  • Phage display with negative selection: Design selection strategies that:

    • Include counter-selection against other AGP family members

    • Isolate AGP18-specific binders through multiple rounds of selection

    • Analyze enrichment patterns to identify highly selective antibody variants

  • Experimental validation matrix:

Validation MethodAGP18AGP17AGP19Other AGPs
Western blotPrimary testCross-reactivity checkCross-reactivity checkSelected members
ELISAAffinity determinationCompetition assayCompetition assaySelected members
ImmunolocalizationMain applicationControl stainingControl stainingAs needed
Knockout controlsAGP18 mutantsAGP17 mutantsAGP19 mutantsAs available
  • Super-Learner classification approach: Apply advanced statistical methods to discriminate between specific and cross-reactive antibodies, with AUC estimates to quantify prediction accuracy .

How can researchers design experiments to use AGP18 antibodies for studying protein-protein interactions in the female gametophyte?

To investigate protein-protein interactions involving AGP18 in the female gametophyte:

  • Co-immunoprecipitation (Co-IP) strategies:

    • Use AGP18 antibodies conjugated to solid support (magnetic beads or agarose)

    • Prepare female gametophyte-enriched extracts through careful microdissection

    • Include appropriate controls (IgG control, AGP18-knockout tissue)

    • Analyze precipitated complexes by mass spectrometry

  • Proximity labeling approaches:

    • Create fusion proteins combining AGP18 with proximity labeling enzymes (BioID or APEX2)

    • Express these constructs under native AGP18 regulatory elements

    • Use AGP18 antibodies to confirm proper localization of fusion proteins

    • Identify proximal proteins through streptavidin pulldown and mass spectrometry

  • In situ proximity ligation assay (PLA):

    • Apply AGP18 antibodies alongside antibodies against candidate interacting proteins

    • Use species-specific secondary antibodies with attached oligonucleotides

    • Visualize protein-protein interactions as fluorescent spots when proteins are within 40nm

    • Quantify interaction frequency in different cell types and developmental stages

  • FRET-based verification:

    • Use AGP18 antibodies labeled with donor fluorophores

    • Label antibodies against putative interaction partners with acceptor fluorophores

    • Measure energy transfer as evidence of protein proximity

    • Perform controls with non-interacting proteins

  • Yeast two-hybrid validation:

    • Use interactions identified through antibody-based methods for targeted Y2H testing

    • Focus on specific domains of AGP18 identified through epitope mapping

    • Verify interactions under physiologically relevant conditions

These approaches can reveal the protein interaction network of AGP18 during female gametophyte development, providing mechanistic insights into its function in reproductive development .

What are the best approaches for overcoming epitope masking when using AGP18 antibodies in plant tissues?

AGP18's complex structure and modifications can lead to epitope masking. To overcome this:

  • Antigen retrieval optimization:

    • Test multiple antigen retrieval methods (heat-mediated, enzymatic, pH-based)

    • Optimize duration and conditions for each tissue type

    • Validate that retrieval doesn't alter tissue morphology or protein localization

  • Epitope-specific antibody development:

    • Generate antibodies against multiple distinct regions of AGP18

    • Target regions less likely to be modified or masked

    • Use synthetic peptides representing exposed regions of the mature protein

  • Sample preparation modifications:

    • Adjust fixation protocols to minimize cross-linking that might mask epitopes

    • Test different permeabilization methods to improve antibody accessibility

    • Consider vibratome sectioning for thick tissues to improve penetration

  • Enzymatic pre-treatments:

    • Apply specific glycosidases to remove glycan modifications that might mask epitopes

    • Optimize enzyme concentration and incubation conditions

    • Include controls to ensure enzymes don't disrupt protein localization

  • Signal amplification methods:

    • Implement tyramide signal amplification (TSA) for weakly detected epitopes

    • Use secondary antibody enhancement systems

    • Apply quantum dot-conjugated secondary antibodies for improved sensitivity

These approaches address the challenges posed by AGP18's complex structure, including its N-terminal signal peptide, extensive glycosylation, and GPI membrane anchor attachment .

How should researchers handle tissue-specific variations in AGP18 expression when conducting immunolocalization studies?

Addressing tissue-specific variations in AGP18 expression requires careful experimental design:

  • Comprehensive sampling strategy:

    • Sample multiple developmental stages to capture temporal variations

    • Include diverse tissue types where AGP18 expression patterns may differ

    • Standardize tissue collection procedures to minimize variability

  • Optimized protocol adaptation:

    • Adjust fixation time based on tissue density and composition

    • Modify permeabilization conditions for tissues with different cell wall properties

    • Optimize antibody concentration for tissues with varying expression levels

  • Quantitative analysis approach:

    • Implement quantitative imaging to measure relative expression levels

    • Use internal references for normalization between tissues

    • Apply statistical methods appropriate for comparing non-normal distributions

  • Expression pattern classification:

    • Document distinct localization patterns systematically:

      • Uniform distribution in sporophytic cells (premeiotic ovules)

      • Polarized distribution in nucellar cells adjacent to functional megaspore

      • Presence within cytoplasmic foci adjacent to nuclei

      • Localization in central cell and egg apparatus but absence in antipodals

  • Integration with transcriptomic data:

    • Correlate protein localization with tissue-specific transcriptome data

    • Identify potential post-transcriptional regulation mechanisms

    • Account for differences between mRNA and protein distribution patterns

This systematic approach helps researchers accurately interpret AGP18 localization across different tissues and developmental contexts, providing a comprehensive understanding of its dynamic expression patterns .

How might emerging antibody technologies advance our understanding of AGP18 function in plant reproduction?

Emerging technologies offer exciting possibilities for AGP18 research:

  • Single-domain antibodies (nanobodies):

    • Develop plant-optimized nanobodies against AGP18

    • Utilize their small size for improved tissue penetration

    • Engineer intrabodies for in vivo tracking of AGP18 in living plant cells

  • Antibody-based proximity proteomics:

    • Combine AGP18 antibodies with proximity labeling enzymes

    • Map the spatiotemporal protein interaction network of AGP18

    • Identify transient interactions during key developmental transitions

  • Super-resolution microscopy applications:

    • Apply STORM or PALM techniques with fluorescently labeled AGP18 antibodies

    • Resolve nanoscale distribution patterns at the plasma membrane

    • Visualize AGP18 clustering and co-localization with other proteins at unprecedented resolution

  • Combinatorial antibody approaches:

    • Develop antibody panels that recognize distinct AGP18 epitopes

    • Apply machine learning to analyze complex binding patterns

    • Use biophysics-informed modeling to interpret binding signatures

  • CRISPR-based epitope tagging:

    • Precisely introduce epitope tags at the endogenous AGP18 locus

    • Generate plant lines with minimally altered AGP18 function

    • Use well-characterized commercial antibodies against these tags for consistent detection

These technologies could reveal new insights into how AGP18 mediates megaspore selection and survival, potentially uncovering previously unknown mechanisms of plant reproductive development .

What are the key considerations for designing longitudinal studies of AGP18 function using antibody-based approaches?

Designing effective longitudinal studies of AGP18 requires careful planning:

  • Temporal sampling strategy:

    • Establish precise developmental staging criteria

    • Define key transitional timepoints:

      • Pre-meiotic MMC formation

      • Meiosis completion

      • Functional megaspore specification

      • Female gametophyte maturation

    • Maintain consistent sampling intervals across experimental replicates

  • Experimental design considerations:

    • Include sufficient biological replicates to account for natural variation

    • Implement paired analysis where possible (same plant sampled over time)

    • Control environmental conditions rigorously to minimize external variables

  • Multi-method integration approach:

MethodApplicationTemporal ResolutionSpatial Resolution
ImmunolocalizationProtein localizationFixed timepointsSubcellular
Promoter-reporterTranscriptional activityContinuous (in vivo)Cellular
qRT-PCRmRNA quantificationFixed timepointsTissue-level
Western blotProtein abundanceFixed timepointsTissue-level
  • Statistical analysis framework:

    • Apply repeated measures analysis for longitudinal data

    • Use mixed-effects models to account for individual variation

    • Implement appropriate multiple testing correction procedures

  • Data integration strategy:

    • Correlate AGP18 expression patterns with developmental outcomes

    • Analyze co-expression with known reproductive regulators

    • Create predictive models of AGP18 function based on spatiotemporal dynamics

This comprehensive approach allows researchers to track AGP18's dynamic role throughout reproductive development, revealing how its expression and localization patterns correlate with functional outcomes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.